Palivizumab

Sibling codes

• XM0QB1 – Motavizumab
• XM0U74 – Raxibacumab
• XM1GU6 – Measles immunoglobulin
• XM1V63 – Staphylococcus immunoglobulin
• XM3FU2 – Pertussis immunoglobulin
• XM3ZS8 – Rubella immunoglobulin
• XM4361 – Anti-D (rh) immunoglobulin
• XM4YT6 – Diphtheria immunoglobulin
• XM54X9 – Obiltoxaximab
• XM5NX5 – Encephalitis, tick borne immunoglobulin
• XM5R25 – Rabies immunoglobulin
• XM6GD5 – Bezlotoxumab
• XM6JK2 – Hepatitis B immunoglobulin
• XM7LD1 – Hepatitis A immunoglobulin
• XM7NM9 – Cytomegalovirus immunoglobulin
• XM7X82 – Varicella zoster immunoglobulin
• XM8824 – Tetanus immunoglobulin
• XM8Q08 – Vaccinia immunoglobulin
• XM8Y60 – Anthrax immunoglobulin
• XM8Z30 – Mumps immunoglobulin

Foundation entity

Palivizumab – http://id.who.int/icd/entity/1069926168